Continuing Education Credits (CMEs and CEUs)
The American Society of Human Genetics (ASHG) Annual Meeting is a forum for the education of physicians in the field of genetics. By attending invited sessions, symposia, and plenary and platform presentation, the physicians will receive both a broad overview of the field and information about the most recent, detailed research on the topic of the session. By attending any of the activities, physicians will better understand the basic science that underlies clinical practice.
Statement of Need
It is important that physicians comprehend the basic science that underlies clinical medicine. The American Society of Human Genetics Annual Meeting is the premier venue for this educational opportunity. Physicians learn about the most up-to-date, cutting-edge discoveries regarding genetics.
Global Learning Objectives
All attendees obtaining CME/CEU credits will be able to apply the newly acquired knowledge and use of methods in the evaluation, diagnosis, intervention, treatment, and follow-up of patients with a variety of disorders.
At the conclusion of the ASHG 2017 Annual Meeting, participants should be able to:
- Identify and fill gaps in knowledge in human genetics in areas of statistical analysis, full genome sequencing, next generation sequencing, genetic neurodegenerative and other disorders, and epigenetics.
- Explain the value and use of newest technological methods in full genome sequencing in diagnosis of disorders and family studies.
- Provide context from discussions on the benefits and harms of returning results of full genome sequencing to patients.
- Set principles for the provision of results and their interpretation in full genome sequencing and the diagnosis of genetic risks.
- Accrue guidelines for the successful counseling of patients receiving complex genetic results.
- Present the newest results of gene therapy trials so clinicians may enroll patients or apply therapies to appropriate patients.
- Identify and explain the newest non-invasive prenatal diagnostic methods.
- Integrate results of genomic testing into electronic health records and other methods to store information.
- Recognize methods to utilize centralized databases in the diagnosis and treatment of patients.
This meeting is targeted to research scientists, clinical and laboratory practitioners, and others interested in the field of human genetics. The program is varied so that participants may select from several concurrent sessions those that fit their specialized research interests and clinical practice applications.
ASHG Annual Meeting attendees include:
- Laboratory geneticists, directors, technicians, and technologists
- Medical and clinical geneticists
- Physicians of all specialties with an interest in genetics, genomics, and the genetic basis of disease
- Genetic counselors
- Biotechnology and pharmaceutical development professionals
- Fellows, trainees, and students
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) and the policy of the American Society of Human Genetics (ASHG), speakers and moderators presenting in sessions that offer CME and CEU credit must disclose, prior to the start of their presentations, the existence of any relevant financial interest and/or other relationship(s) they might have with the manufacturer(s) or provider(s) of any commercial product(s) or service(s), including diagnostic laboratories to be discussed during their presentation. These disclosures are included below. Speakers with disclosures are required to provide a slide that states any relevant financial relationships (or lack thereof), and to state these to the audience at the start of their presentation. All disclosures have been peer reviewed by the ASHG Program Committee subcommittee.
CME, CEU, and P.A.C.E.® CEU credits may be reported by each attendee at the conclusion of the meeting via ASHG’s computerized self-reporting system. To apply for credits, please check the appropriate box on the registration form. A separate, nonrefundable fee is required.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Medical Genetics and Genomics and American Society of Human Genetics. The American College of Medical Genetics and Genomics is accredited by the ACCME to provide continuing medical education for physicians.
The American College of Medical Genetics and Genomics designates this live activity for a maximum of 30.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
There is a nonrefundable $45 fee payable during the registration process. You can apply for credits through the online application available beginning Friday, October 20, 2017. The deadline to submit your request is Friday, December 1, 2017. Attendees may use the mobile application or the Program-at-a-Glance to help track the sessions they attended.
Content Validation and Fair Balance
- ASHG follows the ACCME policy on Content Validation for CME activities, which requires:
- All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in CME in support or justification of patient care recommendations must conform to the generally accepted standards of experimental design, data collection, and analysis.
- Activities that fall outside the definition of CME/CE, “Educational activities that serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession” (source: ACCME and AMA), will not be certified for credit. CME activities that promote recommendations, treatment, or manners of practicing medicine or pharmacy that are not within the definition of CME/CE or, are known to have risks or dangers that outweigh the benefits or, are known to be ineffective in the treatment of patients.
- Presentations and CME/CE activity materials must give a balanced view of therapeutic options; use of generic names will contribute to this impartiality. If the CME/CE educational materials or content includes trade names, where available, trade names from several companies must be used.
Off-Label or Unapproved Use of Drugs or Devices
It is the policy of the ASHG to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Diagnostic and Testing Labs and Commercial Interest
ASHG CME activities adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests - unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest. Diagnostic laboratories, whether not-for-profit or for-profit, that are not owned by device manufacturers are exempted from this CME requirement. However, they are still expected to be fair and balanced in their presentations.
HIPAA Compliance by Speakers
The ASHG supports medical information privacy. While the ASHG is not a “covered entity” under HIPAA 1996 and therefore is not required to meet these standards, ASHG wishes to take reasonable steps to ensure that the presentation of individually identifiable health information at ASHG-sponsored events has been properly authorized. All presenters have completed a form indicating whether they intend to present any form of individually identifiable healthcare information. If so, they were asked either to attest that a HIPAA-compliant consent form is on file at their institution, or to send ASHG a copy of the ASHG HIPAA compliance form. This information is on record at the ASHG Administrative Office and will be made available upon request.
The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of ACMG.
Continuing Education Unit Credits (CEUs) for Genetic Counselors
National Society of Genetic Counselors (NSGC) designates this live activity for a maximum of 3.0 Category 1 CEU (30.5 contact hours). NSGC is approved as an authorized provider of continuing education and training by the International Association for Continuing Education and Training (IACET).
There is a nonrefundable $35 fee payable during the registration process ($25 of the fee is payable to NSGC. $10 covers ASHG administrative fees). . You can apply for credits
through the online application available beginning Friday, October 20, 2017. The deadline to submit your request is Friday, December 1, 2017. Attendees may use the mobile application or the Program-at-a-Glance to help track the sessions they attended.
Genetic Counselors and Nurses should apply for CEUs. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of certification and recertification.
Continuing Education Unit Credits (CEUs) for California-Licensed Clinical and Molecular Laboratory Directors (P.A.C.E.®)
Professional Acknowledgment for Continuing Education (P.A.C.E.®) program for California-Licensed Clinical and Molecular Laboratory Directors designates this live
activity for a maximum 30.5 CEU credits.
There is a nonrefundable $35 fee payable during the registration process. You will need to pick up your CEU packet in the ASHG Meeting Office.You can apply for credits through the online application available beginning Friday, October 20, 2017. The deadline to submit your request is Friday, December 1, 2017. Attendees may use the mobile application or the Program-at-a-Glance to help track the sessions they attended.
Clinical Laboratory Scientists should apply for P.A.C.E. CEUs. ABMGG will accept P.A.C.E. CEUs for diplomats participating in the MOC program in the following categories: Clinical Biochemical Geneticist, Clinical Cytogeneticist, and Clinical Molecular Geneticist.